Eucrates Biomedical Acqui...

NASDAQ: EUCRU · Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Statistics

Share Statistics

Eucrates Biomedical Acquisition has n/a shares outstanding. The number of shares has increased by 0% in one year.

n/a
0%
0%
n/a
1.59M
n/a
n/a

Short Selling Information

The latest short interest is 357, so 0% of the outstanding shares have been sold short.

357
n/a
n/a
999.99

Valuation Ratios

The PE ratio is 5.37 and the forward PE ratio is null. Eucrates Biomedical Acquisition's PEG ratio is 0.12.

5.37
n/a
0
n/a
3.49
-47.22
0.12
Financial Ratio History

Enterprise Valuation

Eucrates Biomedical Acquisition has an Enterprise Value (EV) of 29.8M.

0
-11.57
-47.28
-47.28

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.01.

2.03
2.03
0.01
-0.02
-0.1
0

Financial Efficiency

Return on Equity is 64.88% and Return on Invested Capital is -12.88%.

64.88%
44.36%
-12.88%
n/a
n/a
undefined
0
n/a

Taxes

-3.12M
-128.84%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is -0.07, so Eucrates Biomedical Acquisition's price volatility has been lower than the market average.

-0.07
n/a
10.29
10.07
15.57
581

Income Statement

n/a
n/a
-699K
5.54M
-2.58M
-699K
1.86
Full Income Statement

Balance Sheet

The company has 18.86K in cash and 60.06K in debt, giving a net cash position of -41.2K.

18.86K
60.06K
-41.2K
-3.72M
12.49M
67.06K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -630.29K and capital expenditures 0, giving a free cash flow of -630.29K.

-630.29K
n/a
-630.29K
-0.21
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

EUCRU does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
18.61%
-2.12%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for EUCRU.

n/a
n/a
n/a
n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
10.95
9.28%

Scores

6.58
4